Nancy Wysenski Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Nancy Wysenski.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Nancy Wysenski. Nancy Wysenski is Director in NORTH AMERICAN SCIENTIFIC INC ($NASI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in CYTOKINETICS INC ($CYTK) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Alkermes plc. ($ALKS) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Provention Bio, Inc. ($PRVB).

Latest Insider Trading Transactions of Nancy Wysenski

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALKS, CYTK, DOVA, GEB, NASI, PRVB, TTPH

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 14 2021	PRVB	Provention Bio, In ...	Wysenski Nancy	Director	Option Exercise	A	6.80	23,000	156,400	23,000
May 13 2021	CYTK	CYTOKINETICS INC	Wysenski Nancy	Director	Option Exercise	A	24.32	10,000	243,200	10,000
May 13 2021	CYTK	CYTOKINETICS INC	Wysenski Nancy	Director	Grant	A	0.00	5,000	0	5,459	459 to 5.5 K (+1,089.32 %)
Apr 05 2021	CYTK	CYTOKINETICS INC	Wysenski Nancy	Director	Grant	A	24.44	204	4,986	459	255 to 459 (+80.00 %)
Dec 04 2020	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	0.00	5,578	0	5,578
Dec 04 2020	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	0.00	5,578	0	5,578
Dec 04 2020	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	18.82	11,509	216,599	11,509
Dec 04 2020	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	18.82	11,509	216,599	11,509
Jul 16 2020	PRVB	Provention Bio, In ...	Wysenski Nancy	Director	Option Exercise	A	12.62	22,200	280,164	22,200
May 21 2020	PRVB	Provention Bio, In ...	Wysenski Nancy	Director	Option Exercise	A	13.16	128,981	1,697,390	128,981
Feb 25 2020	ALKS	Alkermes plc.	Wysenski Nancy	Director	Buy	P	19.65	6,940	136,371	11,242	4.3 K to 11.2 K (+161.32 %)
Nov 12 2019	DOVA	Dova Pharmaceutica ...	Wysenski Nancy	Director	Option Exercise	D	9.36	10,000	93,600	0
Nov 12 2019	DOVA	Dova Pharmaceutica ...	Wysenski Nancy	Director	Sell	D	0.00	6,274	0	0	6.3 K to 0 (-100.00 %)
Jun 11 2019	TTPH	TETRAPHASE PHARMAC ...	Wysenski Nancy	Director	Option Exercise	A	0.77	16,500	12,705	16,500
May 23 2019	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	25.04	22,400	560,896	22,400
Apr 30 2019	DOVA	Dova Pharmaceutica ...	Wysenski Nancy	Director	Option Exercise	A	9.36	10,000	93,600	10,000
Mar 18 2019	ALKS	Alkermes plc.	Wysenski Nancy	Director	Buy	P	33.06	445	14,712	4,302	3.9 K to 4.3 K (+11.54 %)
Mar 18 2019	ALKS	Alkermes plc.	Wysenski Nancy	Director	Buy	P	33.09	3,857	127,628	3,857	0 to 3.9 K
Feb 07 2019	DOVA	Dova Pharmaceutica ...	Wysenski Nancy	Director	Grant	A	0.00	6,274	0	6,274	0 to 6.3 K
Jun 26 2018	DOVA	Dova Pharmaceutica ...	Wysenski Nancy	Director	Option Exercise	A	33.47	30,000	1,004,100	30,000
Jun 01 2018	TTPH	TETRAPHASE PHARMAC ...	Wysenski Nancy	Director	Option Exercise	A	3.68	12,500	46,000	12,500
May 24 2018	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	45.64	17,500	798,700	17,500
Jun 01 2017	TTPH	TETRAPHASE PHARMAC ...	Wysenski Nancy	Director	Option Exercise	A	6.89	12,500	86,125	12,500
May 25 2017	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	58.25	14,200	827,150	14,200
Jun 10 2016	TTPH	TETRAPHASE PHARMAC ...	Wysenski Nancy	Director	Option Exercise	A	4.27	10,000	42,700	10,000
May 26 2016	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	43.58	21,600	941,328	21,600
May 16 2016	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	A	9.33	10,000	93,300	10,000
May 16 2016	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	A	0.00	10,000	0	10,000
May 09 2016	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	M	0.00	5,000	0	0
May 09 2016	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Buy	M	0.00	5,000	0	5,000	0 to 5 K
Jun 11 2015	TTPH	TETRAPHASE PHARMAC ...	Wysenski Nancy	Director	Option Exercise	A	42.26	10,000	422,600	10,000
May 29 2015	ALKS	Alkermes plc.	Wysenski Nancy	Director	Option Exercise	A	60.57	16,000	969,120	16,000
May 08 2015	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	A	8.01	7,500	60,075	7,500
May 08 2015	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	A	0.00	5,000	0	5,000
Mar 09 2015	GEB	INOVIO PHARMACEUTI ...	Wysenski Nancy	Director	Option Exercise	A	7.56	18,750	141,750	18,750
May 01 2008	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	D	8.80	25,000	220,000	0
May 01 2008	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	D	3.18	15,000	47,700	0
May 01 2008	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	D	1.92	15,000	28,800	0
May 01 2008	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	D	1.23	15,000	18,450	0
May 01 2008	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	0.42	150,000	63,000	150,000
Jun 06 2007	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	1.23	15,000	18,450	15,000
May 05 2006	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	1.92	15,000	28,800	15,000
Aug 09 2005	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	3.18	15,000	47,700	40,000
Jun 23 2004	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	8.80	25,000	220,000	25,000
Jun 23 2004	NASI	NORTH AMERICAN SCI ...	Wysenski Nancy	Director	Option Exercise	A	8.80	25,000	220,000	25,000

Page: 1